Congratulations to #SlideflowLabs, @UChicago spun out cancer pathology AI company on winning Rattan L. Khosa First Place Prize. #SlideflowLabs enables hospitals to run cancer biomarkers in-house with faster turnaround times. @lab_pearson @UChicagoPath ow.ly/eTYS50Z8NRA

🤖 Join the Artificial Intelligence in Cancer Research Summer School 2025 hosted by @IstTumori- A pioneering event where cutting-edge technology meets life-saving medical innovation. More info ➡️ aicancer2025.org

At #ASCO25, Frederick Howard, MD, presents a poster showing high efficiency of AI models that accurately predicts treatment outcomes in breast cancer patients, offering a faster, more scalable alternative to traditional genomic testing. @fredhow @lab_pearson @UChicagoHemOnc

From ambient dictation tools to FDA-approved diagnostics, #AI is transforming oncology! At #ASCO25, Alexander Pearson, MD, PhD presents how AI is reshaping clinical cancer care—from research to bedside. @UChicagoMed @UChicagoHemOnc @lab_pearson

🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. @UCCancerCenter @UChicagoHemOnc @ajuloorimd @lab_pearson @HNCancerDoc @EIzumchenko @eevokes jamanetwork.com/journals/jam…

Jazzed to see our work describing *potential LLM use trends in @ASCO abstracts* as one of the @JCO_ASCO family top articles of 2024. Check out all the top articles here: ascopubs.org/2024-top-articl…. @fredhow @LGM_Biostats @JCOCCI_ASCO @UCCancerCenter @UChicagoBSD

The #callforabstracts for our annual AI for Oncology conference in @IstTumori (May 8-9, 2025) is open until Feb 3rd - aiforoncology.it/call-for-ab… We really look forward to your submissions! And the top 3 will have the chance to present in front of a stellar lineup - don't miss it!

Thanks so much @BasuLab1 @LovaSunMD @PennHeadandNeck! What a great opportunity to brainstorm science together.

Generative artificial intelligence for drug discovery: how the first AI-discovered and AI-designed drug progressed to phase 2 clinical testing #behindthepaper communities.springernature.c…

Honored to present our translational research at @TheVFoundation symposium. Thank you for the invtation and your support! @UCCancerCenter @UChicagoMed @UChicagoHemOnc @UofC @UChicagoCCB

Very exciting things in the works @UChicagoHemOnc @UChicagoBSD #IYKYK

Incredibly excited to share our open-source Common Longitudinal ICU data Format (CLIF)! We hope CLIF will substantially improve the efficiency of critical illness research and evaluation of important ICU quality measures Appreciate any and all feedback!

🚀 Big news! Slideflow 3.0 is here! 🎉 We've revamped our licensing (now Apache-2.0) to make Slideflow more open & accessible. We've added 3 foundation models (Virchow, UNI, GigaPath), upgraded MIL, & much more. Check it out: github.com/slideflow/slidefl… #AI #Pathology #OpenSource

Fantastic news!

Check out our multi-center phase 2 IIT currently accruing for upfront SBRT added to Durvalumab-based chemoimmunotherapy for the first line treatment of extensive stage SCLC - the DARES trial. @ChristineBestv1 @Docace911 clinical-lung-cancer.com/art…

Looking forward to this terrific session!

U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefro…

Ecstatic to join 1st cohort of #CZBiohubCHI Investigators, with @EsserKahnLab Peter Maurer. Our squad will use quantum-enabled IDs⚛️to eval individual immune cells in real-time to describe disease like malignant transformation🦀. @czbiohub @UChicagoMed @UChicago @UCCancerCenter

Priviliged to have spent 4 days with friends and colleagues from all over the 🌎in the beautiful historic setting of AKSS Spetses for the first “Workshop on AI in Oncology: applications & challenges”. We interacted and learned from AI experts, delved into the exciting new world of AI possibilities and dynamic potentials in oncology, laughed and shared amazing moments in Spetses, the island of unique energy, cherished and celebrated old friendships and fostered new ones, enjoyed a few unforgettable days of togetherness. And also organised and followed our @I3Lung annual meeting, celebrating 2 years of working together! thank you all for coming, each one has and is making an incredible difference and together we rock! Safe travels back home to everyone and see you all next year! ❤️

Ugh. Program termination applies to: TrilynX (NCT04459715) XRAY VISION (NCT05386550)